Skip to main content

Table 3 Distribution of ARV-related adverse events by ARV drug regimen among TB patients receiving ART at MPC, Malawi £

From: Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi

   ARV-related adverse effects Total (n = 284) d4T/3TC/NVP (n = 110) TDF/3TC/EFV (n = 174)
Total with one or more ARV-related adverse events* 82 29% 39 35% 43 25%
   Anorexia 6 2% 2 2% 4 2%
   Leg pain/numbness 40 14% 24 22% 16 9%
   Jaundice 1 0% 0 0% 1 1%
   Skin rash 9 3% 5 5% 4 2%
   Vomit 22 8% 4 4% 18 10%
   Hepatitis 1 0% 0 0% 1 1%
   Abdominal pain 5 2% 2 2% 3 2%
   Fever 5 2% 2 2% 3 2%
   Other 9 3% 5 5% 4 2%
  1. *P-value = 0.052; £ARV = antiretroviral.